Avantium signed capacity reservation agreement with BIOVOX for PEF in pharmaceutical applications

CEO Tom Van Aken and Her Majesty Queen Maxima. Source: Avantium

Avantium, the Dutch company in renewable and circular polymer materials, signed a capacity reservation agreement with BIOVOX, a pioneer in sustainable healthcare plastics. Under this agreement, BIOVOX has committed to using Avantium’s PEF (polyethylene furanoate) in various pharmaceutical applications. This PEF is expected to be produced in a future industrial-scale facility, based on a technology license from Avantium. The multi-year capacity reservation ensures BIOVOX preferred access to PEF volumes produced by Avantium’s future licensee network.

Continue reading

Evonik launches plant-based squalene to boost vaccine efficacy

wpid-evonik_methionine_singapore.jpg

Evonik has launched a non-animal-derived squalene suitable for vaccines and other pharmaceutical applications. PhytoSquene® is the first known amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. It meets the demand for a secure commercial supply of non-animal-derived squalene. Non-GMP samples of PhytoSquene® are available immediately with GMP quality to follow in 2023.

Continue reading

Nouryon joined forces with water treatment company Van Remmen UV Technology

Nouryon joined forces with water treatment company Van Remmen UV Technology on a novel method to address the growing concern of pharmaceutical micropollutants in waste water. The process, which combines the Advanox™ ultraviolet (UV) treatment process from Van Remmen UV Technology and Nouryon’s MicrOx™ hydrogen peroxide, is expected to remove more than 90% of pharmaceutical residues.

Continue reading